BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7876322)

  • 1. Nongenomic actions of the steroid hormone 1 alpha,25-dihydroxyvitamin D3.
    Baran DT
    J Cell Biochem; 1994 Nov; 56(3):303-6. PubMed ID: 7876322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics of a membrane receptor that recognizes 1 alpha,25-dihydroxyvitamin D3 and its epimer, 1 beta,25-dihydroxyvitamin D3.
    Baran DT; Ray R; Sorensen AM; Honeyman T; Holick MF
    J Cell Biochem; 1994 Dec; 56(4):510-7. PubMed ID: 7890809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
    J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression.
    Jenis LG; Lian JB; Stein GS; Baran DT
    J Cell Biochem; 1993 Nov; 53(3):234-9. PubMed ID: 8263040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 alpha,25-Dihydroxyvitamin D3 rapidly increases nuclear calcium levels in rat osteosarcoma cells.
    Sorensen AM; Bowman D; Baran DT
    J Cell Biochem; 1993 Jun; 52(2):237-42. PubMed ID: 8396151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.
    Dormanen MC; Bishop JE; Hammond MW; Okamura WH; Nemere I; Norman AW
    Biochem Biophys Res Commun; 1994 May; 201(1):394-401. PubMed ID: 8198601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical responses to 1alpha,25(OH)2-Vitamin D3 and their physiological significance in osteoblasts.
    Zanello LP; Norman AW
    Steroids; 2004 Aug; 69(8-9):561-5. PubMed ID: 15288770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin II is the membrane receptor that mediates the rapid actions of 1alpha,25-dihydroxyvitamin D(3).
    Baran DT; Quail JM; Ray R; Leszyk J; Honeyman T
    J Cell Biochem; 2000 Apr; 78(1):34-46. PubMed ID: 10797564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
    J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus.
    Farach-Carson MC; Bergh JJ; Xu Y
    Steroids; 2004 Aug; 69(8-9):543-7. PubMed ID: 15288767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells.
    Pavlin D; Bedalov A; Kronenberg MS; Kream BE; Rowe DW; Smith CL; Pike JW; Lichtler AC
    J Cell Biochem; 1994 Dec; 56(4):490-501. PubMed ID: 7890807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts.
    Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z
    Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways.
    Farach-Carson MC; Ridall AL
    Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid actions of 1 alpha-25-dihydroxyvitamin D3 physiologic role.
    Baran DT; Sorensen AM
    Proc Soc Exp Biol Med; 1994 Nov; 207(2):175-9. PubMed ID: 7938047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25(OH)2 vitamin D3 actions on ion channels in osteoblasts.
    Zanello LP; Norman A
    Steroids; 2006 Apr; 71(4):291-7. PubMed ID: 16457860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens.
    Larsson B; Nemere I
    J Cell Biochem; 2003 Dec; 90(5):901-13. PubMed ID: 14624450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nongenomic and genomic effects of 1α,25(OH)2 vitamin D3 in rat testis.
    Zanatta L; Zamoner A; Zanatta AP; Bouraïma-Lelong H; Delalande C; Bois C; Carreau S; Silva FR
    Life Sci; 2011 Oct; 89(15-16):515-23. PubMed ID: 21565203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.